Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status

NCT06713161 · clinicaltrials.gov ↗

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Sentinel Lymph Node
Metastases
Margin Assessment

Interventions

DIAGNOSTIC_TEST: NIR-II Probe(i.e ICG-POL6326) incubation solution

Sponsor

Yunnan Cancer Hospital

Collaborators

[object Object]